← Back to headlines
NeuroSense Therapeutics receives Nasdaq listing deficiency notices
NeuroSense Therapeutics has received notices from Nasdaq concerning its compliance with the exchange's listing requirements.
3 Apr, 14:54 — 3 Apr, 14:54
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Sale Receipt Goes Viral, Drawing Reactions from Bezos and Musk
just now
New Israeli app tracks disaster victims in real time, speeds emergency response
just now
US FCC Deepens Crackdown on Chinese Telecoms, Raising Exit Risk
4m ago
Artemis II Astronauts Return to Earth After Moon Mission
4m ago